Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acadesine in High-Risk CABG (RED-CABG)
NCT00872001Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Apr 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acadesine in coronary artery disease (CAD), sponsored by Merck & Co.. Started Apr 2009; status: terminated.
02
Drugs
acadesine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00872001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872001.